Trials / Unknown
UnknownNCT01657955
Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia
Study of Bendamustine Hydrochloride Injection in Previously Untreated Chronic Lymphocytic Leukemia Patients
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 96 (estimated)
- Sponsor
- Shandong Lanjin Pharmaceuticals Co.,Ltd · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether bendamustine is effective in the treatment of initial treatment of Chronic Lymphocytic Leukemia (CLL).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bendamustine Hydrochloride Injection | |
| DRUG | Chlorambucil |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2013-10-01
- Completion
- 2013-12-01
- First posted
- 2012-08-06
- Last updated
- 2012-08-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01657955. Inclusion in this directory is not an endorsement.